{"title":"Bei myelodysplastischen Syndromen (MDS): Mit Azacitidin möglichst lange behandeln!","authors":"","doi":"10.1055/s-0030-1254863","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":123656,"journal":{"name":"Tumordiagn u Ther","volume":"100 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2010-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Tumordiagn u Ther","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1055/s-0030-1254863","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}